Koninklijke Philips (PHG) Cash from Financing Activities (2009 - 2026)

Koninklijke Philips' (PHG) quarterly Cash from Financing Activities came in at -$26.9 million in Q1 2026, up 46.67% year-on-year from -$18.4 million in Q1 2025, and up 92.82% quarter-over-quarter from -$374.8 million in Q4 2025.

Koninklijke Philips (PHG) Cash from Financing Activities (2009 - 2026) Analysis & Trends

Koninklijke Philips' Cash from Financing Activities history runs 18 years deep, the most recent figure standing at -$26.9 million for Q1 2026.

  • On a quarterly basis, Cash from Financing Activities rose 46.67% year-over-year to -$26.9 million in Q1 2026; TTM through Mar 2026 was $717.8 million, a 258.02% increase from a year earlier, with the FY2025 full-year figure at $124.6 million, up 123.5% from the prior year.
  • Cash from Financing Activities grew to -$26.9 million in Q1 2026 per PHG's latest filing, from -$374.8 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $618.0 million in Q2 2025 and bottomed at -$912.4 million in Q4 2023.
  • The 5-year median for Cash from Financing Activities is -$92.1 million (2024), against an average of -$49.4 million.
  • Across the five-year window, Cash from Financing Activities slumped 149.12% in 2023 and jumped 378.44% in 2024, its largest moves.
  • Year by year, Cash from Financing Activities stood at $372.4 million in 2022, then sank by 345.0% to -$912.4 million in 2023, then surged by 36.87% to -$576.0 million in 2024, then surged by 34.92% to -$374.8 million in 2025, then soared by 92.82% to -$26.9 million in 2026.
  • Per Business Quant, the three latest PHG Cash from Financing Activities figures stand at -$26.9 million (Q1 2026), -$374.8 million (Q4 2025), and $501.5 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 17.31 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -1.51 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -888.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -260.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -451.20 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -25.00 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -26.93 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 21.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Steris 20.59 Bn 20.16 Bn 697.10 Mn -97.90 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -26.93 Mn
Mar 31, 2026 -26.93 Mn
Dec 31, 2025 -374.82 Mn
Dec 31, 2025 -374.82 Mn
Sep 30, 2025 501.52 Mn
Sep 30, 2025 501.52 Mn
Jun 30, 2025 618.05 Mn
Jun 30, 2025 618.05 Mn
Mar 31, 2025 -50.49 Mn
Mar 31, 2025 -50.49 Mn
Dec 31, 2024 -575.97 Mn
Dec 31, 2024 -575.97 Mn
Sep 30, 2024 -337.15 Mn
Sep 30, 2024 -337.15 Mn
Jun 30, 2024 509.37 Mn
Jun 30, 2024 509.37 Mn
Mar 31, 2024 -133.62 Mn
Mar 31, 2024 -133.62 Mn
Dec 31, 2023 -912.40 Mn
Dec 31, 2023 -912.40 Mn